SCHEMBL27745166

SCHEMBL27745166

CC(C)(C)OC(=O)C(CC(=N)C(=O)O)Cc1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ KMT2A Q03164 4/20 0.40
▸ LMNA P02545 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ NLRP3 Q96P20 1/20 0.40
▸ PPARG P37231 4/20 0.40
▸ PPARA Q07869 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ GAA P10253 1/20 0.38
▸ EPHX2 P34913 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ CACNA1B Q00975 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1519961 0.87 KMT2A (0.52) CYP3A4CYP1A2CYP2D6CYP2C9NFKB1
SCHEMBL1519959 0.87 KMT2A (0.52) CYP3A4CYP1A2CYP2D6CYP2C9NFKB1
SCHEMBL27756525 0.82 KMT2A (0.48) KMT2APPARGPPARAMEN1EPHX2
SCHEMBL27766109 0.78 CTSS (0.47) KMT2ALMNAPPARGPPARAMEN1
SCHEMBL191891 0.76 PPARG (0.49) CYP3A4CYP1A2CYP2D6CYP2C9NFKB1
SCHEMBL2685513 0.76 PPARG (0.49) CYP3A4CYP1A2CYP2D6CYP2C9NFKB1
SCHEMBL191892 0.76 PPARG (0.49) CYP3A4CYP1A2CYP2D6CYP2C9NFKB1
SCHEMBL3660504 0.76 KMT2A (0.44) CYP3A4CYP1A2CYP2D6CYP2C9NFKB1
SCHEMBL1915429 0.76 KMT2A (0.52) KMT2APPARGPPARAMEN1EPHX2
SCHEMBL1915428 0.76 KMT2A (0.52) KMT2APPARGPPARAMEN1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101460461-A Process for preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carboxylic acids HOFFMANN LA ROCHE (CH) 2009-06-17 — — CN claimed
CN-101460461-A Process for preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carboxylic acids HOFFMANN LA ROCHE (CH) 2009-06-17 — — CN disclosed
Send feedback